Familial leukaemia: a study of 909 families.

Scandinavian Journal of Haematology
F W GunzI B Houston

Abstract

A family survey was conducted among 909 patients with leukaemia of all types, with the purpose of establishing the incidence of further cases of leukaemia among relatives. Among a total of 41,807 relatives 8,349 were deceased, and the cause of death was objectively confirmed in 5,011. 72 patients had one or more relatives with leukaemia. First degree relatives with leukaemia were much more frequent in families of patients with chronic lymphocytic than in those of patients with chronic granulocytic leukaemia. The incidence of leukaemia among first degree relatives was established to be 2.8-3.0 times, among more distant relatives about 2.3 times, and overall about 2.5 times that expected. This excess is of the order of that observed in relatives of patients with certain solid tumors. Genetic factors may have accounted for much of the excess incidence in chronic lymphocytic and acute leukaemia, but there was little evidence for a genetic background in chronic granulocytic leukaemia. With the possible exception of one family with multiple cases, a simple Mendelian mechanism did not appear to be involved in the leukaemia families investigated. It appeared more likely that a polygenic mechanism led to a heightened susceptibility to t...Continue Reading

References

Aug 1, 1969·Annals of Internal Medicine·J F FraumeniV T DeVita
Sep 27, 1969·British Medical Journal·P H Fitzgerald, J W Hamer
Jan 1, 1973·Scandinavian Journal of Haematology·M SchweitzerJ E Ploem
Aug 1, 1971·Cancer·R H BottomleyP T Condit
Jan 1, 1969·British Medical Bulletin·J H Edwards
Nov 26, 1954·Deutsche medizinische Wochenschrift·G KALIAMPETSOS
Jan 5, 1957·Journal of the American Medical Association·M J JOHNSON
Jul 20, 1957·Journal of the American Medical Association·F GUNZ, W DAMESHEK
Oct 9, 1958·The New England Journal of Medicine·H G CRAMBLETTS NAJJAR
Feb 1, 1962·Archives of Disease in Childhood·W A CAMPBELLW G WADE
Apr 2, 1965·Science·S MILHAM
Apr 29, 1965·The New England Journal of Medicine·C W HEATH, W C MOLONEY
Jun 25, 1955·Journal of the American Medical Association·R C ANDERSON, H W HERMANN
Nov 1, 1959·Annals of Internal Medicine·D V RAZISL F CRAVER
Jul 1, 1952·A.M.A. Archives of Internal Medicine·E B REILLYG E CARPENTER
Jun 1, 1948·British Journal of Cancer·L S PENROSEM N KARN

❮ Previous
Next ❯

Citations

Feb 1, 1988·Tissue Antigens·M S LinetR L Humphrey
Aug 6, 2000·British Journal of Haematology·M R YuilleR S Houlston
Apr 6, 2001·International Journal of Cancer. Journal International Du Cancer·H K MachullaJ Langner
Jun 1, 2002·Leukemia·R S HoulstonM R Yuille
Sep 28, 2018·Current Hematologic Malignancy Reports·Imo J AkpanLucy A Godley
Jan 1, 1979·American Journal of Hematology·F P LiG F Vawter
Apr 1, 1994·European Journal of Epidemiology·Z RadovanovicS Jankovic
Oct 10, 2007·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Mahaut RipertJacqueline Clavel
Dec 17, 2009·Hematology·Andy C Rawstron
Oct 1, 2008·Current Hematologic Malignancy Reports·Richard S Houlston, Daniel Catovsky
Dec 14, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lynn R GoldinMagnus Björkholm
Dec 22, 2019·British Journal of Haematology·Sarah CharrotJude Fitzgibbon
Nov 15, 1980·International Journal of Cancer. Journal International Du Cancer·W WeberM Jeannet
Jan 1, 1992·Cancer·T A SellersH Rothschild
Jan 1, 1993·Cancer Investigation·F Boulad, N A Kernan
Feb 25, 2003·Cytometry. Part B, Clinical Cytometry·Gerald E MartiNeil Caporaso
Jul 30, 2016·Blood·UNKNOWN University of Chicago Hematopoietic Malignancies Cancer Risk Team
Feb 1, 1979·Cancer·A M OorthuysS J Geerts
Jun 29, 2004·International Journal of Hematology·Silvana CapalboVincenzo Liso
Oct 9, 2002·Clinical Obstetrics and Gynecology·Tanja Pejovic, Peter E Schwartz
Aug 9, 2013·Therapeutic Advances in Hematology·Elliot Stieglitz, Mignon L Loh
Jan 16, 2013·The Journal of Experimental Medicine·Mel Greaves
Jun 30, 2019·European Journal of Haematology·Teresa D'AltriBo T Porse
Jul 1, 1994·American Journal of Hematology·M Pérez-EncinasS Tome
Nov 1, 1979·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M J BurridgeJ M Hennemann
Jun 9, 2021·Human Molecular Genetics·Simone FeursteinLucy A Godley
Aug 5, 2005·American Journal of Human Genetics·Gabrielle S SellickRichard S Houlston
Feb 5, 2011·Molecular Cytogenetics·Roger A SchultzMarilyn L Slovak
Oct 7, 2021·Current Hematologic Malignancy Reports·Ahmed AleemElizabeth A Griffiths

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved